Co‐construction of health technology assessment recommendations with patients: An example with cardiac defibrillator replacement

by Marie‐Pascale Pomey, Philippe Brouillard, Isabelle Ganache, Laurie Lambert, Lucy Boothroyd, Caroline Collette, Sylvain Bédard, Alexandre Grégoire, Sandra Pelaez, Olivier Demers‐Payette, Mireille Goetghebeur, Michèle deGuise, Denis Roy
Published 2020-02-01

An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter

by Roopinder K. Sandhu, MD, MPH, Stephen B. Wilton, MD, MSc, Jennifer Cruz, NP-Adult, MN, Clare L. Aztema, MD, MSc, Kendra MacFarlane, MSc, Robert McKelvie, MD, PhD, Laurie Lambert, PhD, Kathy Rush, PhD, RN, Rodney Zimmerman, MD, Garth Oakes, PhD, Mark Deyell, MD, D. George Wyse, MD, PhD, Jafna L. Cox, MD, Allan Skanes, MD
Published 2019-07-01

Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure

by Stephen B. Wilton, MD, MSc, Padma Kaul, PhD, Sunjidatul Islam, MBBS, MSc, Clare L. Atzema, MD, Jennifer Cruz, NP-Adult, MN, Kendra MacFarlane, MSc, Robert McKelvie, MD, PhD, Stephanie Poon, MD, Laurie Lambert, PhD, Kathy Rush, PhD, RN, Marc Deyell, MD, D. George Wyse, MD, PhD, Jafna L. Cox, MD, Allan Skanes, MD, Roopinder K. Sandhu, MD, MPH
Published 2021-05-01